At Scipher Medicine, we are committed to transforming the way providers prescribe drugs as well as the way manufacturers develop new drugs. We have built a molecular map of all protein interactions that identifies genomic signatures and links those to disease and predictive treatment outcomes. Using a routine blood sample to analyze RNA, we can predict if a patient is likely to respond to a targeted therapy before therapy is prescribed. This insight allows patients to start the most effective therapy from day one. For our first commercial product, we have developed PrismRA®, a first-of-its-kind blood test that can predict which patients with rheumatoid arthritis are less likely to respond to TNFi therapies such as Humira® and Enbrel®, so that such patients can go on alternative approved drugs.
Location: United States, Massachusetts, Waltham
Employees: 51-200
Phone: (855) 724-7437
Total raised: $192M
Founded date: 2014
Investors 4
| Date | Name | Website |
| - | Khosla Ven... | khoslavent... |
| - | aMoon Fund | amoon.fund... |
| - | Optum Vent... | optumventu... |
| - | Tachyon Ve... | tachyon.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.02.2022 | IPO | $110M | - |
| 25.03.2021 | Series C | $82M | - |
Mentions in press and media 24
| Date | Title | Description |
| 09.04.2026 | Scipher Medicine Shares Published Data Further Validating RA Patient Outcome Improvement With PrismRA Testing | Every patient deserves a treatment they know will work for them.” — Reg Seeto, CEO, Scipher MedicineBURLINGTON, MA, UNITED STATES, April 9, 2026 /EINPresswire.com/ -- Scipher Medicine, a leader in precision medicine for autoimmune diseases,... |
| 10.03.2026 | Scipher Medicine and Senelix Announce Strategic Collaboration to Advance SL300 Development | Scipher is the leader in immunology precision medicine and we are pleased to be bring this technology to drug development” — Reg Seeto, CEO, Scipher MedicineBALTIMORE, MD, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- Scipher Medicine... |
| 15.01.2025 | The Future of Healthcare: AI and XR Revolutionize Patient Care | The healthcare landscape is evolving. Two powerful forces are at the forefront: artificial intelligence (AI) and extended reality (XR). These technologies are not just buzzwords; they are reshaping how we diagnose, treat, and manage health ... |
| 10.01.2025 | Q&A: The state of medical XR in 2025 | Josh Sackman, president and cofounder of AppliedVR Photo courtesy of AppliedVR In November 2021, California-based virtual reality therapeutic company AppliedVR became the first medical extended reality (XR) company to be granted FDA De Novo... |
| 10.01.2025 | Innovaccer garners $275M to expand health data analytics offerings | Photo: EmirMemedovski/Getty Images San Francisco-based health-data analytics company Innovaccer scored $275 million in a Series F funding round, which was a combination of primary and secondary funding. The round brings the company's total ... |
| 09.01.2025 | OMNY Health Partners with Scipher Medicine to Advance Precision Immunology | What You Should Know: – OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which has the world’s largest immunology clinico-transcriptomics data set and is focused on advanci... |
| 18.12.2024 | Atropos Health + Scipher Medicine Partner to Transform Precision Medicine for Rheumatoid Arthritis | What You Should Know: – Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence, today announced a strategic par... |
| 28.02.2022 | Scipher Medicine Closes $110M Funding | WALTHAM, MA, Scipher Medicine, a precision immunology company, announced the completion of a $110 million financing led by Cowen Healthcare Investments. >> Click here for more funding data on Scipher Medicine >> To export Sc... |
| 24.02.2022 | Scipher Medicine Closes $110M Financing Round | Scipher Medicine, a Waltham, MA-based precision immunology company, raised $110M in funding. The round was led by Cowen Healthcare Investments, with participation from Neuberger Berman, Hitachi Ventures, Laurion Capital, Monashee Investment... |
| 24.02.2022 | Scipher Medicine collects $110M for its drug-matching blood tests | Though still hard at work untangling the biology of patient-specific drug responses, Scipher Medicine has already solved another very important piece of the startup puzzle: fundraising. Less than a year after locking down an $82 million ser... |
Show more